Vista Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2025 ,inter alia, to consider and approve 1. Unaudited Financial ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Vista Pharmaceuticals Ltd has informed BSE that its Board of Directors will meet on August 13, 2025, at the registered office in Hyderabad. The key agenda items are approval of the unaudited financial results for the quarter ended June 30, 2025 (Q1 FY26) and the limited review report from auditors for the same period. The meeting also includes a standard 'any other business with permission of the Chair' clause. The intimation is filed under SEBI Listing Regulations, 2015. No specific financial numbers, guidance, or other business items are disclosed at this stage.
This is a routine pre-results announcement. The actual financial performance, margins, and year-on-year comparisons will only be known after the results are published. No immediate stock price impact expected from the intimation itself, but investors should watch for the Q1 results on or after August 13.